Aurobindo Pharma Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Aurobindo Pharma Quarterly Results    (AUBD)

Here are the latest quarterly results of Aurobindo Pharma. For more details, see the Aurobindo Pharma financial fact sheet and Aurobindo Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Aurobindo Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-18
*
3
Dec-18
*
3
Mar-19
*
3
Jun-19
*
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m47,51452,69752,92254,44656,00557,99461,58459,248 
Other income Rs m2636393231582063093261,156 
Turnover Rs m47,77753,33553,24554,60456,21158,30461,91060,404 
Expenses Rs m37,65141,83342,34742,98244,60346,87048,42246,674 
Gross profit Rs m9,59410,61310,21511,33711,27511,95113,28512,574 
Depreciation Rs m1,6371,6311,8662,4092,4332,5012,3242,555 
Interest Rs m354477501499409371318211 
Profit before tax Rs m7,8669,1448,1708,5878,6389,38810,96810,964 
Tax Rs m1,7542,0482,3112,2782,2442,3292,2853,037 
Profit after tax Rs m6,1127,0965,8596,3106,3957,0608,6837,927 
Gross profit margin %20.220.119.320.820.120.621.621.2 
Effective tax rate %22.322.428.326.526.024.820.827.7 
Net profit margin %12.913.511.111.611.412.214.113.4 
Diluted EPS Rs 10.4 12.1 10.0 10.8 10.9 12.1 14.8 13.5  
Diluted EPS (TTM) Rs 37.4 39.4 40.4 43.4 43.9 43.8 48.6 51.4  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Aurobindo Pharma 1QFY21 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   AMAR REMEDIES  ALEMBIC  SUN PHARMA  DIVIS LABORATORIES  AJANTA PHARMA  

Compare AUROBINDO PHARMA With:   AMAR REMEDIES  ALEMBIC  SUN PHARMA  DIVIS LABORATORIES  AJANTA PHARMA  

Compare AUROBINDO PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Snap 4-Day Winning Streak; JSW Steel and Hindalco Among Top Losers(Closing)

Indian share markets witnessed selling pressure throughout the day today and ended lower.

Views on news

SUN PHARMA at 52 Week High; BSE 500 Index Down 0.5% (Market Updates)

May 11, 2021 | Updated on May 11, 2021

SUN PHARMA share price has hit a 52-week high. It is presently trading at Rs 721. BSE 500 Index is down by 0.5% at 20,096. Within the BSE 500, SUN PHARMA (up 3.2%) and CHENNAI PETROLEUM (up 7.1%) are among the top gainers, while top losers are INTELLECT DESIGN and SAIL.

AUROBINDO PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 25.6% (Quarterly Result Update)

Sep 15, 2020 | Updated on Sep 15, 2020

For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2% (Quarterly Result Update)

Jun 5, 2020 | Updated on Jun 5, 2020

For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Sell in May and Go Away? (Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


May 11, 2021 03:36 PM

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA - MYLAN COMPARISON

COMPARE AUROBINDO PHARMA WITH

MARKET STATS